Atlas Trials

Phase II Trial With Metronomic, Capecitabine Plus Oral Vinorelbine for Metastatic Breast Cancer

Clinical trial NCT01941771 · COMPLETED

Trial details

NCT number
NCT01941771
Sponsor
University of Aarhus
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2012-06-01
Primary completion
2015-01-01
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.